Your browser doesn't support javascript.
loading
Antigen-driven PD-1+ TOX+ BHLHE40+ and PD-1+ TOX+ EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ.
Maschmeyer, Patrick; Heinz, Gitta Anne; Skopnik, Christopher Mark; Lutter, Lisanne; Mazzoni, Alessio; Heinrich, Frederik; von Stuckrad, Sae Lim; Wirth, Lorenz Elias; Tran, Cam Loan; Riedel, René; Lehmann, Katrin; Sakwa, Imme; Cimaz, Rolando; Giudici, Francesco; Mall, Marcus Alexander; Enghard, Philipp; Vastert, Bas; Chang, Hyun-Dong; Durek, Pawel; Annunziato, Francesco; van Wijk, Femke; Radbruch, Andreas; Kallinich, Tilmann; Mashreghi, Mir-Farzin.
Afiliação
  • Maschmeyer P; Deutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Germany.
  • Heinz GA; Deutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Germany.
  • Skopnik CM; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nephrology and Intensive Care Medicine, Berlin, Germany.
  • Lutter L; Center for Translational Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Mazzoni A; Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, Florence, Italy.
  • Heinrich F; Deutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Germany.
  • von Stuckrad SL; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Berlin, Germany.
  • Wirth LE; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin SPZ (Center for Chronically Sick Children), Berlin, Germany.
  • Tran CL; Deutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Germany.
  • Riedel R; Deutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Germany.
  • Lehmann K; Deutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Germany.
  • Sakwa I; Deutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Germany.
  • Cimaz R; Deutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Germany.
  • Giudici F; Anna Meyer Children's Hospital and University of Florence, Florence, Italy.
  • Mall MA; Department of Clinical Sciences and Community Health, University of Milano, Milano, Italy.
  • Enghard P; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Vastert B; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Berlin, Germany.
  • Chang HD; Berlin Institute of Health (BIH), Berlin, Germany.
  • Durek P; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nephrology and Intensive Care Medicine, Berlin, Germany.
  • Annunziato F; Center for Translational Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • van Wijk F; Deutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Germany.
  • Radbruch A; Deutsches Rheuma-Forschungszentrum (DRFZ), Institute of the Leibniz Association, Berlin, Germany.
  • Kallinich T; BCRT/DRFZ Single-Cell Laboratory for Advanced Cellular Therapies - Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.
  • Mashreghi MF; Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, Florence, Italy.
Eur J Immunol ; 51(4): 915-929, 2021 04.
Article em En | MEDLINE | ID: mdl-33296081
ABSTRACT
T lymphocytes accumulate in inflamed tissues of patients with chronic inflammatory diseases (CIDs) and express pro-inflammatory cytokines upon re-stimulation in vitro. Further, a significant genetic linkage to MHC genes suggests that T lymphocytes play an important role in the pathogenesis of CIDs including juvenile idiopathic arthritis (JIA). However, the functions of T lymphocytes in established disease remain elusive. Here we dissect the transcriptional and the clonal heterogeneity of synovial T lymphocytes in JIA patients by single-cell RNA sequencing combined with T cell receptor profiling on the same cells. We identify clonally expanded subpopulations of T lymphocytes expressing genes reflecting recent activation by antigen in situ. A PD-1+ TOX+ EOMES+ population of CD4+ T lymphocytes expressed immune regulatory genes and chemoattractant genes for myeloid cells. A PD-1+ TOX+ BHLHE40+ population of CD4+ , and a mirror population of CD8+ T lymphocytes expressed genes driving inflammation, and genes supporting B lymphocyte activation in situ. This analysis points out that multiple types of T lymphocytes have to be targeted for therapeutic regeneration of tolerance in arthritis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Juvenil / Proteínas de Grupo de Alta Mobilidade / Linfócitos T / Proteínas de Homeodomínio / Proteínas com Domínio T / Fatores de Transcrição Hélice-Alça-Hélice Básicos / Receptor de Morte Celular Programada 1 / Antígenos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Juvenil / Proteínas de Grupo de Alta Mobilidade / Linfócitos T / Proteínas de Homeodomínio / Proteínas com Domínio T / Fatores de Transcrição Hélice-Alça-Hélice Básicos / Receptor de Morte Celular Programada 1 / Antígenos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha